NEW YORK (GenomeWeb) – Biodesix said today that it has completed a $22 million Series F financing round.

The company raised most of the funds through the sale of preferred stock and other securities — the total amount also includes capital previously raised through convertible debt that was converted into equity in this round.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.